CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 2, March/April 2015
AFRICA
79
Key messages
•
HIV infection is a multisystem disease with a diverse
clinical spectrum.
•
HIV-associated vasculopathy is a unique entity confined
mainly to young individuals.
•
The pathogenesis remains largely theoretical and entails
a complex interplay between inflammatory, opportunis-
tic infections and atherosclerotic components.
•
The key histopathological findings include leucocy-
toclastic vasculitis of the vasa vasora, fragmentation
of the internal elastic lamina, variable intimo-medial
calcification, fibromuscular hyperplasia and transmural
inflammation.
•
The availability of HAART has altered the natural histo-
ry of the disease profile, with atherosclerosis emerging as
a potentially ominous therapeutic challenge.
•
Patients are managed along standard vascular surgical
guidelines as universal management guidelines have not
reached consensus to date.
•
Long-term results of intervention are uncertain because
of suboptimal patient compliance.
•
The exact indications for endovascular intervention
require further study.
We thank Mrs M Moodley for administrative support, Dr Y Sing for photo-
graphic assistance, the Bioethics Committee of the University of KwaZulu-
Natal for ethical approval (Protocol BF208/11) and the Medical Education
Partnership Initiative (MEPI) for partial study funding.
References
1.
Bennet NJ, Gilroy SA, Bronze MS, Glatt A, Windle ML. HIV
disease. emedicine.medscape.com.2011
.http://emedicine.medscape.com/article/211316-overview. Accessed December 23/2013.
2.
Busari O, Opadijo O, Adeyemi O. Cardiac diseases in HIV and AIDS.
Internet J Cardiol
2008;
5
(2): 1–13.
3.
Mulaudzi TV. HIV-associated vasculopathy.
CME
2009;
27
(7): 320–322.
4.
Robbs JV, Paruk N. Management of HIV vasculopathy – a South
African experience.
Eur J Vasc Endovasc Surg
2010;
39
(Suppl 1): S25–
S31.
5.
Joshi VV, Pawel B, Connor E,
et al
. Arteriopathy in children with
acquired immune deficiency syndrome.
Pediatr Pathol
1987;
7
(3):
261–275.
6.
Chetty R. Vasculitides associated with HIV infection.
J Clin Pathol
2001;
54
(4): 275-–278.
7.
Johnson RM, Barbarini G, Barbaro G. Kawasaki-like syndromes
and other vasculitic syndromes in HIV-infected patients.
AIDS
2003;
17
(Suppl 1): S7–S82.
8.
Naidoo NG, Beningfield SJ. Other manifestations of HIV vasculopathy.
S Afr J Surg
2009;
47
(2): 46–53.
9.
Patel N, Patel N, Khan T, Patel N, Espinoza LR. HIV infection and
clinical spectrum of associated vaculitides.
Curr Rheumatol Rep
2011;
13
: 506–512.
10. Stankovic K, Miailhes P, Bessis D, Ferry T, Broussolle C, Séve P.
Kawasaki-like syndromes in HIV-infected adults.
J Infect
2007;
55
(6):
488–494.
11. Woolgar JD, Robbs JV. Vascular surgical complications of the acquired
immunodeficiency syndrome.
Eur J Vasc Endovasc Surg
2002;
24
(6):
473–479.
12. Benjamin LA, Bryer A, Emsley HCA, Khoo S, Solomon T, Conner
MD. HIV infection and stroke: current perspectives and future direc-
tions.
Lancet Neurol
2012;
11
(10): 878–890.
13. Guillevin L, Cohen P. Management of virus-induced systemic vascu-
litides.
Curr Rheumatol Rep
2002;
4
(1): 60–66.
14. Monseuz JJ, Charniot JC, Escaut L,
et al
. HIV-associated vascular
diseases: structural and functional changes, clinical implications.
Int J
Cardiol
2009;
133
(3): 293–306.
15. Nieuwhof CMG, Damoiseaux J, Tervaert JWC. Successful treatment of
cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment.
Ann Rheum Dis
2006;
65
(12): 1677–1678.
16. Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on
HIV-associated vascular disease and endothelial dysfunction.
World J
Surg
2007;
31
(4): 632–643.
17. Maggi P, Ingrassia F, D’Annunzio M. Endothelial inflammatory disease
and cardiovascular risk in HIV patients.
HAART Correlated Pathol
2008;
1
: 19–25.
18. Schecter AD, Berman AB, Yi L,
et al
. HIV envelope gp120 activates
human smooth muscle cells.
Proc Natl Acad Sci USA
2001;
98
(18):
10142–10147.
19. Eugenin EA, Morgello S, KlotmanME,
et al
. Human Immunodeficiency
Virus (HIV) infects human arterial smooth muscle cells in vivo and in
vitro. Implications for the pathogenesis of HIV-mediated vascular
disease.
Am J Pathol
2008;
172
(4): 1100–1111.
20. Gutierrez J, Glenn M, Isaacson RS, Marr AD, Mash D, Petito C.
Thinning of the arterial media layer as a possible preclinical stage in
HIV vasculopathy: a pilot study.
Stroke
2012;
43
(4): 1156–1158.
21. Tilson MD 3rd, Withers L. Arterial aneurysms in HIV patients: molecu-
lar mimicry versus direct infection?
Ann NY Acad Sci
2006;
1085
(Nov):
387–391.
22. Mulaudzi TV, Robbs JV, Pillay W,
et al
. Thrombectomy in HIV
related peripheral arterial thrombosis: a preliminary report.
Eur J Vasc
Endovasc Surg
2005;
30
(1): 102–106.
23. Pipitone N, Salvarani C. The role of infectious agents in the pathogen-
esis of vasculitis.
Best Pract Res Clin Rheumatol
2008;
22
(5): 897–911.
24. Du Pont JR, Bonavita JA, DiGiovanni RJ, Spector HB, Nelson SC.
Acquired immunodeficiency syndrome and mycotic abdominal aneu-
rysms: a new challenge? Report of a case.
J Vasc Surg
1989;
10
(3):
254–257.
25. Bayley AC. Surgical pathology of HIV infection: lessons from Africa.
Br
J Surg
1990;
77
(8): 863–868.
26. Heikkinen MA, Dake MD, Alsac J-M, Zarins CK. Multiple HIV-related
aneurysms: open and endovascular treatment.
J Endovasc Ther
2005;
12
(3): 405–410.
27. Kuskov SI. Arterial pseudoaneurysms as the initial clinical manifestita-
tion of HIV Infection (Abstract).
East Cent Afr J Surg
2006;
11
(1):
94–98.
28. Marks C, Kuskov S. Pattern of arterial aneurysms in acquired immuno-
deficiency disease.
World J Surg
1995;
19
(1): 127–132.
29. Nair R, Abdool-Carrim ATO, Chetty R, Robbs JV. Arterial aneurysms
in patients infected with human immunodeficiency virus: a distinct clin-
icopathology entity?
J Vasc Surg
1999;
29
(4): 600–607.
30. Nair R, Robbs JV, Naidoo NG. Spontaneous carotid artery aneurysms.
Br J Surg
2000;
87
(2): 186–190.
31. Nair R, Robbs JV, Naidoo NG, Woolgar J. Clinical Profile of HIV–
related aneurysms.
Eur J Vasc Endovasc Surg
2000;
20
(3): 235–240.
32. Woolgar JD, Ray R, Maharaj K, Robbs JV. Colour Doppler and grey
scale ultrasound features of HIV-related vascular aneurysms.
Br J
Radiol
2002;
75
(899): 884–888.